Whitney Ijem
Stock Analyst at Canaccord Genuity
(4.47)
# 311
Out of 5,113 analysts
116
Total ratings
53.47%
Success rate
21.64%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Whitney Ijem
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMRN BioMarin Pharmaceutical | Upgrades: Buy | $84 → $98 | $56.78 | +72.60% | 9 | Jan 20, 2026 | |
| TNYA Tenaya Therapeutics | Maintains: Buy | $6 → $5 | $0.71 | +608.22% | 7 | Dec 18, 2025 | |
| PVLA Palvella Therapeutics | Maintains: Buy | $148 → $204 | $86.98 | +134.54% | 8 | Dec 16, 2025 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $114 → $141 | $103.39 | +36.38% | 10 | Dec 12, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $19 → $40 | $13.25 | +201.89% | 2 | Dec 9, 2025 | |
| GUTS Fractyl Health | Maintains: Buy | $6 → $8 | $2.18 | +266.97% | 2 | Nov 21, 2025 | |
| GBIO Generation Bio Co. | Maintains: Buy | $9 → $10 | $5.68 | +76.06% | 3 | Aug 18, 2025 | |
| PASG Passage Bio | Maintains: Buy | $260 → $67 | $12.45 | +438.15% | 7 | Aug 14, 2025 | |
| TSHA Taysha Gene Therapies | Maintains: Buy | $11 → $14 | $4.72 | +196.61% | 11 | Aug 13, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $136 → $128 | $24.31 | +426.53% | 9 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $424 → $411 | $476.84 | -13.81% | 9 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $390 → $415 | $361.35 | +14.85% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $3.63 | +175.48% | 9 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $74 → $54 | $13.95 | +287.10% | 6 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $68 → $66 | $7.36 | +796.74% | 6 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $148 → $150 | $22.80 | +557.89% | 3 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $137.78 | - | 2 | Jan 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $120 → $240 | $6.65 | +3,509.02% | 4 | Jul 23, 2019 |
BioMarin Pharmaceutical
Jan 20, 2026
Upgrades: Buy
Price Target: $84 → $98
Current: $56.78
Upside: +72.60%
Tenaya Therapeutics
Dec 18, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $0.71
Upside: +608.22%
Palvella Therapeutics
Dec 16, 2025
Maintains: Buy
Price Target: $148 → $204
Current: $86.98
Upside: +134.54%
Rhythm Pharmaceuticals
Dec 12, 2025
Maintains: Buy
Price Target: $114 → $141
Current: $103.39
Upside: +36.38%
Wave Life Sciences
Dec 9, 2025
Maintains: Buy
Price Target: $19 → $40
Current: $13.25
Upside: +201.89%
Fractyl Health
Nov 21, 2025
Maintains: Buy
Price Target: $6 → $8
Current: $2.18
Upside: +266.97%
Generation Bio Co.
Aug 18, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $5.68
Upside: +76.06%
Passage Bio
Aug 14, 2025
Maintains: Buy
Price Target: $260 → $67
Current: $12.45
Upside: +438.15%
Taysha Gene Therapies
Aug 13, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $4.72
Upside: +196.61%
Ultragenyx Pharmaceutical
Aug 8, 2025
Maintains: Buy
Price Target: $136 → $128
Current: $24.31
Upside: +426.53%
Aug 6, 2025
Maintains: Hold
Price Target: $424 → $411
Current: $476.84
Upside: -13.81%
Aug 1, 2025
Maintains: Buy
Price Target: $390 → $415
Current: $361.35
Upside: +14.85%
Jul 25, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $3.63
Upside: +175.48%
Jun 3, 2025
Maintains: Buy
Price Target: $74 → $54
Current: $13.95
Upside: +287.10%
May 13, 2025
Maintains: Buy
Price Target: $68 → $66
Current: $7.36
Upside: +796.74%
Nov 7, 2024
Maintains: Buy
Price Target: $148 → $150
Current: $22.80
Upside: +557.89%
Jan 21, 2020
Downgrades: Neutral
Price Target: n/a
Current: $137.78
Upside: -
Jul 23, 2019
Upgrades: Overweight
Price Target: $120 → $240
Current: $6.65
Upside: +3,509.02%